Tag Archives: Reuters

U.S. Study Raises New Concern for Zika Spread; Congress Back, but Just 19 Days Left to Solve Zika Funding Impasse.

According to a Reuters report, a new study has found genetic fragments of Zika in the eyes and the tears of laboratory mice infected with the virus–a finding that offers… Read more »

Mylan Plans Generic EpiPen to Calm Pricing Outrage; Feels More Like a PR Move

Mylan NV’s latest attempt to deflect criticism over the price of allergy shot EpiPen failed to get the drugmaker out of the crosshairs of Congress this week. Last week, Chief… Read more »

Drugmakers’ Pricing Power Helped by Exclusivity Rights: JAMA

The U.S., which spends more on drugs than any other country, might contain costs by limiting market exclusivity for brand-name medicines and changing coverage requirements for government health plans, some… Read more »

DEA Ignores the Evidence; Keeps Marijuana on Parity with Heroin

In a long-awaited announcement, the U.S. Drug Enforcement Administration denied requests to loosen the classification of marijuana as a dangerous drug with no medical use. The decision, reported by Reuters,… Read more »

HHS Can’t Wait for Congress; Shifts $81 Million from NIH for Zika Fight

The U.S. Department of Health and Human Services has shifted $81 million in funds from other projects to continue work on developing vaccines to fight the Zika virus in the absence of… Read more »

Aetna Said to Meet with DOJ on Friday about Humana Deal

Aetna Inc. (Hartford CT) executives met with top Justice Department antitrust officials on Friday to convince the government that asset sales it proposed would address potential competitive problems that could… Read more »

Will Surgery Robots Lead to Better Health Outcomes

Letting robots perform surgery independently may ultimately improve outcomes for patients, researchers say. In experiments on pigs, surgical stitches made by autonomous robots were as good as, or better than,… Read more »